Canlyniadau Chwilio - Claus Høgdall

Mireinio'r Canlyniadau
  1. 1
    Prognostic value of the 2018 FIGO staging system for cervical cancer

    Prognostic value of the 2018 FIGO staging system for cervical cancer gan Abdulaziz Mohamud, Claus Høgdall, Tine Henrichsen Schnack

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  2. 2
    Potential use of DNA methylation in cervical swabs for early ovarian cancer diagnosis

    Potential use of DNA methylation in cervical swabs for early ovarian cancer diagnosis gan Edyta Biskup, Joanna Lopacinska‐Jørgensen, Claus Høgdall, Estrid Høgdall

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  3. 3
    Soluble Urokinase Plasminogen Activator Receptor Measurements: Influence of Sample Handling

    Soluble Urokinase Plasminogen Activator Receptor Measurements: Influence of Sample Handling gan Rikke Riisbro, Ib Jarle Christensen, Claus Høgdall, Nils Brünner, Estrid Høgdall

    Cyhoeddwyd 2001
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  4. 4
    Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study

    Lymph-vascular space invasion (LVSI) as a strong and independent predictor for non-locoregional recurrences in endometrial cancer: a Danish Gynecological Cancer Group Study gan Gitte Ørtoft, Lisa Lausten-Thomsen, Claus Høgdall, Estrid Stæhr Hansen, Margit Dueholm

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  5. 5
    Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers

    Ovarian sex cord-stromal cell tumors and the risk of sex hormone-sensitive cancers gan Sven Karstensen, Kirsten Jochumsen, Claus Høgdall, Estrid Høgdall, Niels Marcussen, Finn Friis Lauszus

    Cyhoeddwyd 2025
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  6. 6
    Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study

    Different Risk Factor Profiles for Mucinous and Nonmucinous Ovarian Cancer: Results from the Danish MALOVA Study gan Marie Soegaard, Allan Jensen, Estrid Høgdall, Lise Christensen, Claus Høgdall, Jan Blaakær, Susanne K. Kjær

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  7. 7
    Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus

    Oncomine™ Comprehensive Assay v3 vs. Oncomine™ Comprehensive Assay Plus gan Lau K. Vestergaard, Douglas V.N.P. Oliveira, Tim Svenstrup Poulsen, Claus Høgdall, Estrid Høgdall

    Cyhoeddwyd 2021
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  8. 8
    Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer

    Identification and validation of potential prognostic and predictive miRNAs of epithelial ovarian cancer gan Kira Philipsen Prahm, Claus Høgdall, Mona Aarenstrup Karlsen, Ib Jarle Christensen, Guy Wayne Novotny, Estrid Høgdall

    Cyhoeddwyd 2018
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  9. 9
    Danish Gynecological Cancer Database

    Danish Gynecological Cancer Database gan S. Soerensen, Signe Frahm Bjørn, Kirsten Jochumsen, Pernille Tine Jensen, Ingrid Thranov, Helle Hare‐Bruun, Lene Seibæk, Claus Høgdall

    Cyhoeddwyd 2016
    Cael y testun llawn Cael y testun llawn
    Revisão
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  10. 10
    Risk of recurrence, prognosis, and follow‐up for Danish women with cervical cancer in 2005‐2013: A national cohort study

    Risk of recurrence, prognosis, and follow‐up for Danish women with cervical cancer in 2005‐2013: A national cohort study gan Gry Assam Taarnhøj, Ib Jarle Christensen, Henrik Lajer, Katrine Fuglsang, Mette Moustgaard Jeppesen, Henriette Strøm Kahr, Claus Høgdall

    Cyhoeddwyd 2017
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  11. 11
    Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma

    Distribution of HER‐2 overexpression in ovarian carcinoma tissue and its prognostic value in patients with ovarian carcinoma gan Estrid Høgdall, Lise Christensen, Susanne K. Kjær, Jan Blaakær, Johannes E. Bock, Eva Glud, Bent Nørgaard‐Pedersen, Claus Høgdall

    Cyhoeddwyd 2003
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  12. 12
    Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: From the ‘MALOVA’ Ovarian Cancer Study

    Prognostic value of estrogen receptor and progesterone receptor tumor expression in Danish ovarian cancer patients: From the ‘MALOVA’ Ovarian Cancer Study gan Susanne K. Kjær, Ib Jarle Christensen, Ian Jacobs, Simon A. Gayther, Lise Christensen, Claus Høgdall, Jan Blaakær, Estrid Høgdall

    Cyhoeddwyd 2007
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  13. 13
    Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer

    Hormone Therapy and the Impact of Estrogen Intake on the Risk of Ovarian Cancer gan Eva Glud, Susanne K. Kjær, Birthe Lykke Thomsen, Claus Høgdall, Lise Christensen, Estrid Høgdall, Johannes E. Bock, Jan Blaakær

    Cyhoeddwyd 2004
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  14. 14
    Socioeconomic Position and Stage of Cervical Cancer in Danish Women Diagnosed 2005 to 2009

    Socioeconomic Position and Stage of Cervical Cancer in Danish Women Diagnosed 2005 to 2009 gan Else Helene Ibfelt, Susanne K. Kjær, Christoffer Johansen, Claus Høgdall, Marianne Steding‐Jessen, Kirsten Frederiksen, Birgitte Frederiksen, Merete Osler, Susanne Oksbjerg Dalton

    Cyhoeddwyd 2012
    Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  15. 15
    Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass

    Diagnostic plasma miRNA-profiles for ovarian cancer in patients with pelvic mass gan Douglas V.N.P. Oliveira, Anting Liu Carlsen, Niels H. H. Heegaard, Kira Philipsen Prahm, Ib Jarle Christensen, Claus Høgdall, Estrid Høgdall

    Cyhoeddwyd 2019
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  16. 16
    'Socioeconomic position and survival after cervical cancer: influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010

    'Socioeconomic position and survival after cervical cancer: influence of cancer stage, comorbidity and smoking among Danish women diagnosed between 2005 and 2010 gan Else Helene Ibfelt, Susanne K. Kjær, Claus Høgdall, Marianne Steding‐Jessen, Trille Kristina Kjær, Merete Osler, Christoffer Johansen, Kirsten Frederiksen, Susanne Oksbjerg Dalton

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  17. 17
    YKL-40 tissue expression and plasma levels in patients with ovarian cancer

    YKL-40 tissue expression and plasma levels in patients with ovarian cancer gan Estrid Høgdall, Merete Ringsholt, Claus Høgdall, Ib Jarle Christensen, Julia S. Johansen, Susanne K. Kjær, Jan Blaakær, Lene Ostenfeld-Møller, Paul A. Price, Lise Christensen

    Cyhoeddwyd 2009
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  18. 18
    <i>BRCA1</i> and <i>BRCA2</i> Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark

    <i>BRCA1</i> and <i>BRCA2</i> Mutation Prevalence and Clinical Characteristics of a Population-Based Series of Ovarian Cancer Cases from Denmark gan Marie Soegaard, Susanne K. Kjær, Mark J. Cox, Eva Wozniak, Estrid Høgdall, Claus Høgdall, Jan Blaakær, Ian Jacobs, Simon A. Gayther, Susan J. Ramus

    Cyhoeddwyd 2008
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  19. 19
    <scp>HE</scp>4 and <scp>CA</scp>125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (<scp>ENDOMET</scp>)

    <scp>HE</scp>4 and <scp>CA</scp>125 levels in the preoperative assessment of endometrial cancer patients: a prospective multicenter study (<scp>ENDOMET</scp>) gan Sofie Leisby Antonsen, Estrid Høgdall, Ib Jarle Christensen, Magnus Christian Lydolph, Ann Tabor, Annika Loft Jakobsen, Carsten Lindberg Fagö-Olsen, E. Andersen, Kirsten Jochumsen, Claus Høgdall

    Cyhoeddwyd 2013
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:
  20. 20
    Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment

    Prognostic relevance of the molecular classification in high-grade endometrial cancer for patients staged by lymphadenectomy and without adjuvant treatment gan Alicia León‐Castillo, Nanda Horeweg, Elke E.M. Peters, Tessa Rutten, Natalja T. ter Haar, Vincent T.H.B.M. Smit, Cor D. de Kroon, Marie Boennelycke, Estrid Høgdall, Claus Høgdall, Remi R.A. Nout, Carien L. Creutzberg, Gitte Ørtoft, Tjalling Bosse

    Cyhoeddwyd 2022
    Cael y testun llawn Cael y testun llawn
    Artigo
    Ychwanegu at ffefrynnau
    Wedi'i Gadw mewn:

Offerynnau Chwilio: